Revenue Quarterly Reports Quarterly Earnings Fourth Quarter Profit Net Income Quarterly Results Adjusted Earnings Sales Earnings Per Share
The plan seeks $1.7 billion in annual savings by 2027 to reinvest in its pipeline ahead of Keytruda’s patent expiry